Curated News
By: NewsRamp Editorial Staff
May 07, 2026
HeartBeam Expands to Southern California with Atelier Health Deal
TLDR
- HeartBeam's expansion into Southern California via Atelier Health gives it a competitive edge in the concierge medicine market.
- HeartBeam's cable-free 3D ECG synthesizes signals into a 12-lead ECG, with FDA clearance for arrhythmia assessment.
- HeartBeam's remote monitoring technology enables earlier cardiac detection, improving patient outcomes and reducing hospital visits.
- HeartBeam's 3D ECG is the first cable-free device to collect signals from three non-coplanar directions.
Impact - Why it Matters
This news matters because it signals a tangible step toward broader access to advanced remote cardiac monitoring. By partnering with a concierge practice like Atelier Health, HeartBeam is demonstrating its technology's value in real-world settings, potentially paving the way for insurance coverage and wider adoption. For patients, this means more convenient, proactive heart health management without frequent clinic visits. For the healthcare industry, it represents a shift toward cable-free, 3D ECG monitoring that could reduce costs and improve early detection of cardiac conditions. Investors should note the company's expanding market footprint and FDA clearances as indicators of growing commercial viability.
Summary
HeartBeam (NASDAQ: BEAT), a pioneering medical technology company focused on cardiac care, has announced a commercial agreement with Atelier Health, a Beverly Hills-based concierge medical practice. This partnership expands HeartBeam's launch footprint into Southern California, completing its initial targeted markets alongside New York metro, Dallas, and South Florida. The company is advancing the commercialization of its cable-free 3D ECG technology for remote cardiac monitoring and preventive cardiology. The technology is designed to collect ECG signals in 3D from three non-coplanar directions and synthesize them into a 12-lead ECG, enabling physicians to identify cardiac health trends and acute conditions outside of medical facilities. This innovative platform received FDA clearance for arrhythmia assessment in December 2024 and for the 12-lead ECG synthesis software in December 2025. HeartBeam holds over 20 issued patents related to its technology.
The agreement with Atelier Health, a practice known for personalized, high-touch medical care, underscores the growing demand for advanced remote monitoring solutions in concierge medicine. By integrating HeartBeam's technology, Atelier Health can offer its patients a cable-free device that delivers actionable heart intelligence, potentially catching cardiac issues early and directing patients to appropriate care. This move aligns with HeartBeam's strategy to target high-end medical practices and health-conscious consumers who prioritize preventive care. The company's expansion into Southern California marks a significant milestone, as it now has a presence in four key U.S. markets, positioning it for broader adoption.
For investors, the latest news and updates relating to BEAT are available in the company's newsroom. The full press release can be accessed at the provided link. The collaboration with Atelier Health not only validates HeartBeam's technology but also highlights the increasing integration of digital health tools in premium healthcare settings. As remote monitoring becomes more mainstream, HeartBeam's 3D ECG technology could redefine cardiac health management by making it more accessible and convenient, potentially reducing hospital visits and improving patient outcomes. The company's cleared indications for use are detailed on its website, offering transparency on the technology's capabilities.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, HeartBeam Expands to Southern California with Atelier Health Deal
